LEAP-004: Durable Responses in Advanced Melanoma Achieved With Lenvatinib Plus Pembrolizumab
In patients with melanoma and confirmed progression on a PD-1, lenvatinib plus pembrolizumab demonstrated clinically meaningful responses.
Skin Cancer
DermDx: Red Nodule on Scalp
During a skin examination, a protuberant reddened nodule is found on the scalp of a 62-year-old man that was partially covered by his hair. Can you make the diagnosis?
Neoadjuvant Nivolumab Plus Relatlimab Produced a High pCR Rate in Stage III-IV Melanoma
Rates of relapse-free and overall survival were high as well, exceeding 90%.
Greater Benefit With Pembrolizumab in Crossover vs Rechallenged Patients With Cutaneous Melanoma
Patients were more likely to benefit from pembrolizumab if they had not previously received the drug.
Adjuvant Pembrolizumab Improves RFS, Not OS, in Resected High-Risk Melanoma
Pembrolizumab bested high-dose interferon alfa-2b and high-dose ipilimumab.
Many Americans Confused About Sunscreens: Poll
As the Memorial Day weekend begins, many Americans are confused about the proper application of sunscreen and about its sun protection factor (SPF), the American Academy of Dermatology says.
Invasive Cutaneous SCC in Patients Taking Antihypertensive Agents
The dermatoscopic characteristics of keratinizing skin cancer in patients prescribed antihypertives treatment is compared with that of non-users.
Mohs Micrographic Surgery Outcomes Associated with Treatment Facility Factors
The link between treatment center academic affiliation and patient volume with long-term patient survival after Mohs micrographic surgery (MMS) was evaluated.
Lifileucel Could Be a New Standard of Care for Patients With Heavily Pretreated Metastatic Melanoma
Lifileucel has produced responses lasting more than 2 years in patients with limited treatment options.
New Checkpoint Inhibitor Relatlimab Works With Nivolumab to Improve PFS in Melanoma
This is the first phase 3 study to validate LAG-3 inhibition as a therapeutic strategy in cancer, according to an investigator.
- Loading...
Loading...
Next post in Skin Cancer
Loading... 
Loading...